Short Interest in Clearmind Medicine Inc. (NASDAQ:CMND) Increases By 319.1%

Clearmind Medicine Inc. (NASDAQ:CMND) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totaling 300,100 shares, an increase of 319.1% from the September 15th total of 71,600 shares. Based on an average trading volume of 739,600 shares, the short-interest ratio is currently 0.4 days. Approximately 10.1% of the company’s stock are sold short. Approximately 10.1% of the company’s stock are sold short. Based on an average trading volume of 739,600 shares, the short-interest ratio is currently 0.4 days.

Clearmind Medicine Price Performance

CMND stock opened at $0.96 on Monday. Clearmind Medicine has a fifty-two week low of $0.80 and a fifty-two week high of $2.18. The business has a 50-day moving average of $1.01 and a 200-day moving average of $0.99. The stock has a market capitalization of $5.24 million, a P/E ratio of -1.26 and a beta of 0.99.

Clearmind Medicine (NASDAQ:CMND) last posted its quarterly earnings data on Thursday, September 11th. The company reported ($0.25) earnings per share (EPS) for the quarter.

About Clearmind Medicine

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.